Systematic review, 2026
Are there differences in brain activity in women with PMDD?
Yes, women with PMDD show differences in brain activity compared to women without PMDD, particularly in areas involved in emotion regulation and stress processing.
What they did
They reviewed fMRI brain imaging studies comparing brain activity in 294 women with PMDD to 304 healthy control women.
What they found
Women with PMDD showed decreased activity in brain regions involved in emotion regulation (anterior cingulate cortex, dorsolateral prefrontal cortex, medial orbitofrontal cortex, postcentral gyrus) and increased activity in emotion-processing regions (amygdala, insula). They also had weaker connections between regulatory and emotional brain regions.
What it means for you
PMDD involves widespread differences in how the brain regulates emotions and processes stress, not just one area. These differences might explain why about 40 percent of women with PMDD do not respond to standard medication. Limitation: brain imaging results vary between studies.
598
total participants
294
women with PMDD
40%
don't respond to SSRIs
About the study
- Original title
- Functional MRI evidence of brain alterations in premenstrual dysphoric disorder: a systematic review
- Authors
- Bartoszewicz K, Szurowska E
- Journal
- Frontiers in psychiatry
- Year
- 2026
- Study design
- Systematic review
- What was tested
- None - observational brain imaging study
- Open access
- Yes
- Read the paper
- doi.org/10.3389/fpsyt.2026.1795420
Original abstract
Introduction: Premenstrual Dysphoric Disorder (PMDD) affects approximately 1.6% of women of reproductive age and significantly impacts quality of life. Despite its prevalence, the underlying pathophysiology remains incompletely understood. First-line treatment typically involves selective serotonin reuptake inhibitors (SSRIs); however, approximately 40 percent of women with PMDD do not respond to these medications. This systematic review synthesizes current evidence on functional brain alterations in women with PMDD, as assessed using functional magnetic resonance imaging (fMRI), with the goal of identifying potential novel therapeutic strategies. Methods: Data from 598 participants, including 294 PMDD patients and 304 healthy controls, were analyzed. Results: The findings suggest alterations in both topdown regulatory mechanisms and large-scale brain networks, including the salience network, default mode network, and executive control network. These alterations are characterized by decreased activation in the anterior cingulate cortex, dorsolateral prefrontal cortex, medial orbitofrontal cortex, and postcentral gyrus, alongside increased activation in the amygdala and insula, as well as impairments in corticolimbic connectivity. Discussion: These results highlight the complexity of PMDD, implicating widespread neural circuits rather than a single localized dysfunction. Targeting these mechanisms may inform the development of novel interventions for symptom relief. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD420251174749.
Reproduced under CC-BY.
Topics
Related studies
Randomised trial, 2023
Does taking sertraline when PMDD symptoms start improve how well women function?
Review, 2019
What is the current evidence for diagnosing and treating PMDD, especially in Indian women?
Review, 2009
What causes PMDD and what are the treatment options?
Review, 2005
Do antidepressants improve quality of life in women with PMDD?
Randomised trial, 2003
Do SSRIs (antidepressants) help PMDD?
Randomised trial, 2002
Does taking fluoxetine only during the luteal phase help PMDD?